NASDAQ : MDXG

MiMedx Group, Inc. — Financial statements

Healthcare · Biotechnology · United States

Last price 3.88 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 566.19M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Financial statements

MiMedx Group, Inc. (MDXG) reported revenue of 303.73M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.

Income statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Revenue303.73M418.63M348.88M321.48M267.84M242.02M
Cost of Revenue68.98M73.01M60.07M54.63M48.32M39.63M
Gross Profit234.75M345.62M288.81M266.84M219.53M202.39M
Selling, General & Admin244.40M266.19M216.39M216.30M220.85M198.64M
Research & Development14.47M15.10M12.34M12.66M12.70M9.93M
Amortization of Goodwill & Intangibles1.02M439.00K765.00K762.00K701.00K820.00K
Operating Expenses259.88M281.73M229.50M229.73M234.25M209.39M
Operating Income-25.14M63.89M59.31M37.12M-14.73M-7.00M
Interest Expense-1.40M-1.78M-3.94M-6.58M-5.05M-4.98M
Interest & Investment Income4.75M4.72M2.93M118.00K32.00K
Other Non Operating Income (Expenses)-593.00K-558.00K-565.00K-26.00K-4.00K-23.00K
EBT Excluding Unusual Items-22.38M66.26M57.74M30.63M-19.75M-12.00M
Asset Writedown-446.00K-53.00K
Pretax Income-22.38M66.26M57.29M30.63M-19.75M-12.05M
Income Tax Expense-3.19M17.68M15.30M-36.81M206.00K247.00K
Earnings From Continuing Operations-19.19M48.58M42.00M67.44M-19.95M-12.30M
Earnings From Discontinued Operations421.00K-9.21M-10.24M2.02M
Net Income-19.19M48.58M42.42M58.23M-30.20M-10.29M
Preferred Dividends & Other Adjustments11.64M6.58M6.14M
Net Income to Common-19.19M48.58M42.42M46.59M-36.78M-16.42M
Shares Outstanding (Basic)147.54M147.79M146.98M116.50M112.91M110.35M
Shares Outstanding (Diluted)147.54M149.72M149.05M145.96M112.91M110.35M
EPS (Basic)-0.130.330.290.40-0.33-0.15
EPS (Diluted)-0.130.320.280.36-0.33-0.15
Free Cash Flow19.12M72.97M64.52M24.79M-19.41M-5.20M
Free Cash Flow Per Share0.130.490.430.17-0.17-0.05
Gross Margin77.29%82.56%82.78%83.00%81.96%83.63%
Operating Margin-8.28%15.26%17.00%11.54%-5.50%-2.89%
Profit Margin-6.32%11.60%12.16%14.49%-13.73%-6.78%
Free Cash Flow Margin6.30%17.43%18.49%7.71%-7.25%-2.15%
EBITDA-17.31M78.77M65.35M40.54M-10.68M-1.81M
EBITDA Margin-5.70%18.82%18.73%12.61%-3.99%-0.75%
D&A For EBITDA7.83M14.88M6.04M3.43M4.05M5.18M
EBIT-25.14M63.89M59.31M37.12M-14.73M-7.00M
EBIT Margin-8.28%15.26%17.00%11.54%-5.50%-2.89%
Effective Tax Rate26.69%26.70%
Advertising Expenses500.00K600.00K600.00K200.00K100.00K

Balance sheet

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Cash & Equivalents120.79M166.12M104.42M82.00M65.95M87.08M
Cash & Short-Term Investments120.79M166.12M104.42M82.00M65.95M87.08M
Accounts Receivable37.27M75.71M55.83M53.87M43.08M40.35M
Other Receivables743.00K
Receivables37.27M75.71M55.83M53.87M43.08M41.10M
Inventory22.09M25.34M23.81M21.02M13.18M11.39M
Prepaid Expenses5.62M7.32M6.15M
Other Current Assets7.08M10.30M7.83M1.75M4.67M2.81M
Total Current Assets187.23M277.47M191.89M164.26M134.20M148.52M
Property, Plant & Equipment4.71M9.06M11.55M9.11M11.26M13.86M
Goodwill19.44M19.44M19.44M19.44M19.44M19.98M
Other Intangible Assets11.12M14.16M11.63M5.26M5.85M5.38M
Long-Term Deferred Tax Assets29.22M19.60M28.31M40.78M
Long-Term Deferred Charges500.00K
Other Long-Term Assets12.33M2.93M1.11M205.00K683.00K186.00K
Total Assets264.55M342.65M263.92M239.05M171.43M187.93M
Accounts Payable11.83M14.53M7.41M9.05M8.45M7.38M
Accrued Expenses23.34M39.03M30.23M29.78M26.68M29.81M
Current Portion of Long-Term Debt1.50M1.00M1.00M
Current Portion of Leases1.32M1.31M1.55M1.44M1.25M
Other Current Liabilities7.87M7.88M5.65M4.63M6.98M3.91M
Total Current Liabilities43.03M64.27M45.59M46.01M43.56M42.36M
Long-Term Debt16.47M17.83M48.10M48.59M48.13M
Long-Term Leases3.25M4.71M898.00K2.44M3.92M
Other Long-Term Liabilities10.44M2.13M2.68M1.32M2.33M951.00K
Total Liabilities53.47M86.11M70.81M96.33M96.92M95.35M
Common Stock149.00K148.00K147.00K146.00K114.00K113.00K
Additional Paid-In Capital300.86M299.08M284.22M276.25M173.80M165.69M
Retained Earnings-77.06M-42.68M-91.26M-133.68M-191.91M-161.71M
Treasury Stock-12.86M-4.02M
Total Common Equity211.08M256.55M193.11M142.72M-17.99M82.00K
Shareholders' Equity211.08M256.55M193.11M142.72M74.51M92.58M
Total Liabilities & Equity264.55M342.65M263.92M239.05M171.43M187.93M
Total Debt22.53M24.84M51.55M52.47M53.29M
Net Cash (Debt)120.79M143.59M79.57M30.45M13.48M33.79M
Net Cash Per Share0.820.960.530.210.120.31
Filing Date Shares Outstanding145.93M148.57M147.37M146.96M113.96M111.48M
Total Common Shares Outstanding145.93M148.09M146.93M146.23M113.58M111.05M
Working Capital144.20M213.21M146.29M118.25M90.64M106.17M
Book Value Per Share1.451.731.310.98-0.160.00
Tangible Book Value180.52M222.95M162.04M118.02M-43.28M-25.28M
Tangible Book Value Per Share1.241.511.100.81-0.38-0.23
Machinery18.00M17.75M17.50M15.94M31.44M31.54M
Construction In Progress1.45M612.00K686.00K1.79M1.98M397.00K
Leasehold Improvements8.96M8.98M8.21M8.14M9.19M9.05M

Cash flow statement

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Net Income-19.19M48.58M42.42M58.23M-30.20M-10.29M
Depreciation & Amortization7.83M14.88M6.04M3.43M4.05M5.18M
Other Amortization1.05M
Loss (Gain) From Sale of Assets262.00K
Asset Writedown & Restructuring Costs53.00K
Stock-Based Compensation4.88M16.40M16.93M16.96M11.33M14.16M
Provision & Write-off of Bad Debts10.94M6.51M595.00K1.45M2.82M
Other Operating Activities-5.90M10.61M6.57M-26.71M12.04M-946.00K
Change in Accounts Receivable28.54M-26.39M-2.55M-12.24M-5.94M-10.62M
Change in Inventory4.41M-1.53M-2.36M-7.84M-1.79M-1.41M
Change in Accounts Payable714.00K2.12M-1.41M783.00K839.00K-159.00K
Change in Other Net Operating Assets-11.48M2.83M885.00K876.00K-1.12M-7.17M
Operating Cash Flow20.74M74.00M66.20M26.77M-17.89M-1.98M
Capital Expenditures-1.62M-1.03M-1.68M-1.99M-1.51M-3.22M
Cash Acquisitions-5.00M-3.76M-7.86M
Sale (Purchase) of Intangibles-97.00K-252.00K
Investment in Securities-89.00K-2.09M-38.00K-168.00K
Other Investing Activities-1.15M75.00K
Investing Cash Flow-6.80M-6.89M-9.58M-2.15M-2.66M-3.40M
Short-Term Debt Issued30.00M
Long-Term Debt Issued19.78M
Total Debt Issued49.78M
Short-Term Debt Repaid-30.00M
Long-Term Debt Repaid-1.00M-51.50M-38.00K
Total Debt Repaid-18.25M-1.00M-81.50M-38.00K
Net Debt Issued (Repaid)-18.25M-1.00M-31.72M-38.00K
Issuance of Common Stock1.40M997.00K651.00K1.44M
Repurchase of Common Stock-14.92M-3.12M-2.64M-1.19M-4.75M
Other Financing Activities-2.06M-1.29M-1.24M-52.00K-41.00K
Financing Cash Flow-35.23M-5.41M-34.20M-8.57M-580.00K-3.35M
Net Cash Flow-21.29M61.70M22.42M16.05M-21.13M-8.73M
Free Cash Flow19.12M72.97M64.52M24.79M-19.41M-5.20M
Free Cash Flow Margin6.30%17.43%18.49%7.71%-7.25%-2.15%
Free Cash Flow Per Share0.130.490.430.17-0.17-0.05
Levered Free Cash Flow26.70M63.34M50.52M24.82M-4.30M-4.07M
Unlevered Free Cash Flow27.58M64.45M52.98M28.93M-1.14M-2.02M
Cash Interest Paid863.00K1.25M2.70M6.03M4.57M4.33M
Cash Income Tax Paid6.32M8.51M3.25M-548.00K181.00K169.00K
Change in Working Capital22.18M-22.98M-5.43M-18.42M-8.01M-19.35M

Ratios

Fiscal year January - December; amounts in USD.

TTMFY2025FY2024FY2023FY2022FY2021
Market Capitalization478.64M1.00B1.41B1.02B315.53M670.50M
Enterprise Value357.84M878.78M1.34B1.08B390.73M726.18M
Last Close Price3.886.779.628.772.786.04
PE Ratio20.6433.3321.91
Forward PE21.6132.8935.0812.6712.67
PS Ratio1.622.404.053.171.182.77
PB Ratio2.683.917.327.154.247.24
P/TBV Ratio2.724.508.728.65
P/FCF Ratio25.7213.7421.9141.17
P/OCF Ratio23.7113.5521.3538.11
PEG Ratio0.840.840.840.840.84
EV/Sales Ratio1.222.103.853.371.463.00
EV/EBITDA Ratio11.1620.5626.70
EV/EBIT Ratio13.7622.6629.17
EV/FCF Ratio19.4012.0420.8343.67
Debt / Equity Ratio0.090.130.360.700.58
Debt / EBITDA Ratio0.280.371.23
Debt / FCF Ratio0.310.392.08
Net Debt / Equity Ratio-0.57-0.56-0.41-0.21-0.18-0.36
Net Debt / EBITDA Ratio6.98-1.82-1.22-0.751.2618.62
Net Debt / FCF Ratio-6.32-1.97-1.23-1.230.696.50
Asset Turnover1.041.381.391.571.491.24
Inventory Turnover2.842.972.683.193.933.64
Quick Ratio3.673.763.522.952.503.03
Current Ratio4.354.324.213.573.083.51
Return on Equity (ROE)-8.53%21.61%25.01%62.09%-23.88%-13.37%
Return on Assets (ROA)-5.38%13.17%14.74%11.30%-5.12%-2.24%
Return on Invested Capital (ROIC)-26.79%41.36%38.51%42.84%-24.58%-13.18%
Return on Capital Employed (ROCE)-11.30%22.90%27.20%19.20%-11.50%-4.80%
Earnings Yield-3.97%4.84%3.00%5.71%-9.57%-1.53%
FCF Yield3.89%7.28%4.56%2.43%-6.15%-0.78%
Buyback Yield / Dilution1.32%-0.45%-2.11%-29.27%-2.32%-1.94%